Yield10 Bioscience, Inc.
YTEN · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $1,900 | $8,205 | $23,281 | $13,717 |
| - Cash | $1,068 | $2,356 | $5,329 | $3,423 |
| + Debt | $3,205 | $2,650 | $3,163 | $3,620 |
| Enterprise Value | $4,037 | $8,499 | $21,115 | $13,914 |
| Revenue | $60 | $450 | $614 | $799 |
| % Growth | -86.7% | -26.7% | -23.2% | – |
| Gross Profit | -$230 | -$206 | $36 | -$4,421 |
| % Margin | -383.3% | -45.8% | 5.9% | -553.3% |
| EBITDA | -$14,127 | -$13,188 | -$11,472 | -$9,427 |
| % Margin | -23,545% | -2,930.7% | -1,868.4% | -1,179.8% |
| Net Income | -$14,455 | -$13,566 | -$11,031 | -$10,206 |
| % Margin | -24,091.7% | -3,014.7% | -1,796.6% | -1,277.3% |
| EPS Diluted | -43.66 | -66.25 | -55.95 | -103.21 |
| % Growth | 34.1% | -18.4% | 45.8% | – |
| Operating Cash Flow | -$10,068 | -$11,404 | -$9,253 | -$8,659 |
| Capital Expenditures | -$46 | -$154 | -$189 | -$76 |
| Free Cash Flow | -$10,114 | -$11,558 | -$9,442 | -$8,735 |